-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
-
14
-
15
Retracted: Short lipopeptides specifically inhibit the growth of Propionibacterium acnes with dual antibacterial and anti‐inflammatory action, by G Yang, J Wang, S Lu, et al. British Journal of Pharmacology, volume 176(11): 1603–1618, published in May 2019: DOI 10.1111/bph.14571
Veröffentlicht in British journal of pharmacology
VolltextArtikel -
16
‘EP1‐ and FP‐mediated cross‐desensitization of the alpha (α) and beta (β) isoforms of the human thromboxane A2 receptor’, by LP Kelley‐Hickie and T Kinsella. British Journal of Pharmacology, volume 142(1): 203–221, published in May 2004; DOI 10.1038/sj.bjp.0705695
Veröffentlicht in British journal of pharmacology
VolltextArtikel -
17
'EP 1 - and FP-mediated cross-desensitization of the alpha (α) and beta (β) isoforms of the human thromboxane A 2 receptor', by LP Kelley-Hickie and T Kinsella. British Journal of Pharmacology, volume 142(1): 203-221, published in May 2004; DOI 10.1038/sj.bjp.0705695
Veröffentlicht in British journal of pharmacology
VolltextArtikel -
18
Retracted: Addition of a single methyl group to a small molecule sodium channel inhibitor introduces a new mode of gating modulation, by L Wang, SG Zellmer, DM Printzenhoff and NA Castle. British Journal of Pharmacology, volume 172(20): 4905–4918, published in October 2015; DOI 10.1111/bph.13259
Veröffentlicht in British journal of pharmacology
VolltextArtikel -
19
Retracted: Mice lacking the Raf‐1 kinase inhibitor protein exhibit exaggerated hypoxia‐induced pulmonary hypertension, by IMorecroft, BDoyle, MNilsen, WKolch, KMair and MRMacLean. British Journal of Pharmacology, volume 163(5): 948–963, published in June 2011; DOI 10.1111/j.1476‐5381.2011.01305.x
Veröffentlicht in British journal of pharmacology
VolltextArtikel -
20
Retracted: Cannabinoid CB(2) receptors modulate ERK‐1/2 kinase signalling and NO release in microglial cells stimulated with bacterial lipopolysaccharide, by S Merighi, S Gessi, K Varani, C Simioni, D Fazzi, P Mirandola and P A Borea. British Journal of Pharmacology, volume 165(6): 1773–1788, published in March 2012; DOI 10.1111/j.1476‐5381.2011.01673.x
Veröffentlicht in British journal of pharmacology
VolltextArtikel